Clinical Trials

Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 341 - 360 of 449 trials
Title Investigatorsort icon Disease(s)
A Phase IA/B Study of CC-115 in Castration-Resistant Prostate Cancer
[Protocol 12-080] 		Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase III Study of Cabozantinib versus Prednisone in Metastatic Castration-Resistant Prostate Cancer after Prior Treatment
[Protocol 12-274] 		Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Study of Degarelix Before Prostatectomy in Patients with Intermediate- to High-Risk Prostate Cancer
[Protocol 11-182] 		Rathkopf, Dana
  • Prostate Cancer
    • Localized Disease
A Phase III Study of Everolimus versus Placebo in Patients with Neuroendocrine Tumors Originating in the Lungs or Gastrointestinal Tract: The RADIANT-4 Study
[Protocol 12-250] 		Reidy-Lagunes, Diane
  • Lung Cancer
  • Upper Gastrointestinal
    • Neuroendocrine
A Phase II Study of GSK2118436 in Patients with Advanced Non-Small Cell Lung Cancer and BRAF Mutations
[Protocol 11-023] 		Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of Crizotinib and STA-9090 in ALK-Positive Lung Cancers
[Protocol 12-015] 		Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of the ALK Inhibitor CH5424802 in Patients with ALK-Rearranged Non-Small Cell Lung Cancer
[Protocol 12-113] 		Riely, Gregory
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Trial of AUY-922 in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib
[Protocol 11-015] 		Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114] 		Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of LDK378 in Adults with Non-Small Cell Lung Cancers Containing an ALK Gene Fusion
[Protocol 11-055] 		Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of SNX-5422 plus Erlotinib in Patients with Lung Cancer that Has Grown on Erlotinib Therapy
[Protocol 13-035] 		Riely, Gregory
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222] 		Riely, Gregory
  • Lung Cancer, Non-Small Cell
Phase I Study of PF-02341066 in People with Advanced Cancer
[Protocol 07-157] 		Riely, Gregory
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003] 		Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111] 		Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
  • Lung Cancer, Small Cell
    • Other
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Cancer
[Protocol 11-037] 		Rizk, Nabil
  • Upper Gastrointestinal
    • Esophageal Cancer
A Prospective Study to Determine if Variations in Tissue Oxygenation Are Associated with Leak Rates after Esophagectomy
[Protocol 11-192] 		Rizk, Nabil
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097] 		Rizvi, Naiyer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase III Study of BMS-936558 versus Docetaxel in Patients with Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
[Protocol 12-252] 		Rizvi, Naiyer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Other
A Phase I Study of BMS-936558 with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189] 		Rizvi, Naiyer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
On Our Blog